Compare DLNG & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLNG | OPRX |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | Greece | United States |
| Employees | N/A | 129 |
| Industry | Marine Transportation | Business Services |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.0M | 115.4M |
| IPO Year | N/A | 2008 |
| Metric | DLNG | OPRX |
|---|---|---|
| Price | $4.27 | $5.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 128.2K | ★ 443.6K |
| Earning Date | 03-13-2026 | 03-05-2026 |
| Dividend Yield | ★ 4.66% | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | $12.26 |
| Revenue Next Year | $0.37 | $10.41 |
| P/E Ratio | ★ $3.04 | $22.74 |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $3.18 | $5.54 |
| 52 Week High | $4.45 | $22.25 |
| Indicator | DLNG | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.26 | 31.38 |
| Support Level | $3.46 | $5.54 |
| Resistance Level | $4.45 | $14.28 |
| Average True Range (ATR) | 0.23 | 0.59 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 71.74 | 18.03 |
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.